All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Single or double induction with 7 + 3 containing standard or high-dose daunorubicin for newly diagnosed AML: the randomized daunodouble trial by the study Alliance Leukemia

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F25%3A00013722" target="_blank" >RIV/00023736:_____/25:00013722 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11120/25:43927555 RIV/65269705:_____/25:00081020 RIV/00064173:_____/25:43927555

  • Result on the web

    <a href="https://doi.org/10.1200/JCO.24.00235" target="_blank" >https://doi.org/10.1200/JCO.24.00235</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1200/JCO.24.00235" target="_blank" >10.1200/JCO.24.00235</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Single or double induction with 7 + 3 containing standard or high-dose daunorubicin for newly diagnosed AML: the randomized daunodouble trial by the study Alliance Leukemia

  • Original language description

    To determine the optimal daunorubicin dose and number of 7 + 3 induction cycles in newly diagnosed AML, this randomized controlled trial compared a once daily dose of 60 mg/m2 with 90 mg/m2 daunorubicin in the first 7 + 3 induction and one versus two cycles of 7 + 3 induction. The use of 90 mg/m2 daunorubicin once daily in the context of classical 7 + 3 induction does not significantly improve early response and does not lead to higher remission rates or longer survival than 60 mg/m2 once daily. In patients with a good early response after first induction, a second induction has only a limited impact on RFS and does not result in an OS benefit.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30205 - Hematology

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of clinical oncology

  • ISSN

    0732-183X

  • e-ISSN

  • Volume of the periodical

    43

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    12

  • Pages from-to

    65-74

  • UT code for WoS article

    001091456900051

  • EID of the result in the Scopus database

    2-s2.0-85204701862